Guoping Jiang

Title: Guoping Jiang: Innovator in Pharmaceutical Chemistry

Introduction

Guoping Jiang is a notable inventor based in Zhejiang, China, recognized for his contributions to pharmaceutical chemistry. He has been instrumental in developing innovative compounds that have significant applications in medicine. With a total of two patents to his name, Jiang's work focuses on macrolide derivatives and tetrahydroisoquinoline derivatives.

Latest Patents

Jiang's latest patents include a macrolide derivative, which is represented by a specific formula. This derivative has been identified as an inhibitor of various protein kinases, including TRK, ALK, and ROS1. Additionally, he has developed a tetrahydroisoquinoline derivative, which also has a defined formula. This compound is particularly noteworthy for its application as a therapeutic agent, specifically as an angiotensin II type 2 receptor (ATR) antagonist. The preparation methods and applications of these derivatives highlight Jiang's innovative approach to drug development.

Career Highlights

Throughout his career, Guoping Jiang has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Zhejiang Hisun Pharmaceutical Co., Ltd. and Shanghai Aryl Pharmtech Co., Ltd. His experience in these organizations has allowed him to contribute significantly to the field of pharmaceutical research and development.

Collaborations

Jiang has collaborated with several professionals in his field, including Taishan Hu and Lei Chen. These collaborations have further enhanced his research capabilities and have led to the successful development of his patented compounds.

Conclusion

Guoping Jiang's innovative work in pharmaceutical chemistry, particularly in the development of macrolide and tetrahydroisoquinoline derivatives, showcases his significant contributions to medicine. His patents reflect a commitment to advancing therapeutic options for various medical conditions.